455 related articles for article (PubMed ID: 9886575)
1. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
Liao DZ; Pantazis CG; Hou X; Li SA
Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of androgen and estrogen on the mouse uterus and mammary gland.
Zhang J; Sun Y; Liu Y; Sun Y; Liao DJ
Oncol Rep; 2004 Oct; 12(4):709-16. PubMed ID: 15375489
[TBL] [Abstract][Full Text] [Related]
3. An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats.
Cheung SY; Yuen MT; Choi HL; Cheng HK; Huang Y; Chen S; Chan FL
Int J Oncol; 2003 Jun; 22(6):1383-95. PubMed ID: 12739009
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone-induced mammary carcinogenesis in female noble rats: the role of androgens.
Xie B; Tsao SW; Wong YC
Carcinogenesis; 1999 Aug; 20(8):1597-606. PubMed ID: 10426813
[TBL] [Abstract][Full Text] [Related]
6. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression.
Zhou J; Ng S; Adesanya-Famuiya O; Anderson K; Bondy CA
FASEB J; 2000 Sep; 14(12):1725-30. PubMed ID: 10973921
[TBL] [Abstract][Full Text] [Related]
7. Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.
Montero Girard G; Vanzulli SI; Cerliani JP; Bottino MC; Bolado J; Vela J; Becu-Villalobos D; Benavides F; Gutkind S; Patel V; Molinolo A; Lanari C
Breast Cancer Res; 2007; 9(2):R22. PubMed ID: 17341305
[TBL] [Abstract][Full Text] [Related]
8. The role of androgens in mammary carcinogenesis.
Wong YC; Xie B
Ital J Anat Embryol; 2001; 106(2 Suppl 1):111-25. PubMed ID: 11729946
[TBL] [Abstract][Full Text] [Related]
9. Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis.
Xie B; Tsao SW; Wong YC
Breast Cancer Res Treat; 2000 May; 61(1):45-57. PubMed ID: 10930089
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
[TBL] [Abstract][Full Text] [Related]
11. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation.
Li SA; Weroha SJ; Tawfik O; Li JJ
J Endocrinol; 2002 Nov; 175(2):297-305. PubMed ID: 12429028
[TBL] [Abstract][Full Text] [Related]
12. Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis.
Xie B; Tsao SW; Wong YC
Breast Cancer Res Treat; 1999 Dec; 58(3):227-39. PubMed ID: 10718485
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway.
Thordarson G; Slusher N; Leong H; Ochoa D; Rajkumar L; Guzman R; Nandi S; Talamantes F
Breast Cancer Res; 2004; 6(4):R423-36. PubMed ID: 15217511
[TBL] [Abstract][Full Text] [Related]
15. The effect of flutamide and tamoxifen on sex hormone-induced mammary carcinogenesis and pituitary adenoma.
Leung G; Tsao SW; Wong YC
Breast Cancer Res Treat; 2002 Mar; 72(2):153-62. PubMed ID: 12038706
[TBL] [Abstract][Full Text] [Related]
16. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments.
Thordarson G; Semaan S; Low C; Ochoa D; Leong H; Rajkumar L; Guzman RC; Nandi S; Talamantes F
Breast Cancer Res Treat; 2004 Oct; 87(3):277-90. PubMed ID: 15528971
[TBL] [Abstract][Full Text] [Related]
17. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.
Harvell DM; Strecker TE; Tochacek M; Xie B; Pennington KL; McComb RD; Roy SK; Shull JD
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2779-84. PubMed ID: 10688907
[TBL] [Abstract][Full Text] [Related]
18. Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones.
Thordarson G; Van Horn K; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Jul; 22(7):1027-33. PubMed ID: 11408345
[TBL] [Abstract][Full Text] [Related]
19. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
Moreno-Cuevas JE; Sirbasku DA
In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
[TBL] [Abstract][Full Text] [Related]
20. Induction of high incidence of mammary tumour in female Noble rats with a combination of 17beta-oestradiol and testosterone.
Xie B; Tsao SW; Wong YC
Carcinogenesis; 1999 Jun; 20(6):1069-78. PubMed ID: 10357790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
